<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Transl Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Transl Psychiatry</journal-id><journal-title-group><journal-title>Translational Psychiatry</journal-title></journal-title-group><issn pub-type="epub">2158-3188</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40188067</article-id><article-id pub-id-type="pmc">PMC11972385</article-id><article-id pub-id-type="publisher-id">3342</article-id><article-id pub-id-type="doi">10.1038/s41398-025-03342-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Examining the vulnerability of adult neuron subtypes to tau-mediated toxicity in <italic>Drosophila</italic></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0009-5160-2697</contrib-id><name><surname>Sivanantharajah</surname><given-names>Lovesha</given-names></name><address><email>l.sivanantharajah@bangor.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mudher</surname><given-names>Amrit</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Shepherd</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/006jb1a24</institution-id><institution-id institution-id-type="GRID">grid.7362.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 1882 0937</institution-id><institution>School of Environmental and Natural Sciences, </institution><institution>Bangor University, </institution></institution-wrap>Bangor, Gwynedd UK </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ryk1543</institution-id><institution-id institution-id-type="GRID">grid.5491.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9297</institution-id><institution>Faculty of Natural and Environmental Sciences, </institution><institution>University of Southampton, </institution></institution-wrap>Southampton, UK </aff></contrib-group><pub-date pub-type="epub"><day>5</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>5</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><elocation-id>127</elocation-id><history><date date-type="received"><day>8</day><month>8</month><year>2024</year></date><date date-type="rev-recd"><day>26</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Selective vulnerability of nerve cells is a feature of neurodegenerative disease. To date, animal models have been limited to examining pathogenic protein expression in broad or heterogeneous neuronal populations. Consequently, noted pathological hallmarks represent an average of disease phenotypes over multiple neuron types, rather than exact measures of individual responses. Here we targeted gene expression to small, precisely defined and homogenous neuronal populations in the <italic>Drosophila melanogaster</italic> central nervous system (CNS), allowing dissection of selective vulnerability of single types of neurons with <italic>single-neuron resolution</italic>. Using cellular degeneration as a readout for vulnerability, we found while all neurons were affected by tau some neuron types were more affected (vulnerable) than others (resilient). The tau-mediated pathogenic effects fell on a spectrum, demonstrating that neurons in the fly CNS are <italic>differentially vulnerable</italic> to tau pathology. Mechanistically, total tau levels did not correlate with vulnerability; rather, the best correlatives of degeneration were significant age-dependent increases in phospho-tau levels in the same neuron type, and tau mislocalisation into dendrites. Lastly, we found that tau phosphorylation in vulnerable neuron types correlated with downstream vesicular and mitochondrial trafficking defects. However, all vulnerable neuron types did not show the same pattern, suggesting multiple paths to degeneration. Beyond highlighting the heterogeneity of neuronal responses to tau in determining vulnerability, this work provides a new, high-resolution, tractable model for studying the age-dependent effects of tau, or any pathogenic protein, on postmitotic neurons with sub-cellular resolution.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Diseases</kwd><kwd>Neuroscience</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000320</institution-id><institution>Alzheimer's Society</institution></institution-wrap></funding-source><award-id>315</award-id><award-id>574</award-id><principal-award-recipient><name><surname>Sivanantharajah</surname><given-names>Lovesha</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Neurodegenerative disorders share two characteristics: accumulation of pathological proteins and progressive selective deterioration of specific neuronal subtypes. Tauopathies, like Alzheimer&#x02019;s Disease (AD), are marked by neuronal aggregation of hyper-phosphorylated tau, a microtubule associated protein (MAPT) required for microtubule stability [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. Typically, progressive deterioration of neurons in AD begins in brain regions involved in memory before progressing to connected cortical areas [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. This is interesting because tau expression is ubiquitous across the brain. That tau does not become pathogenic in all neurons, strongly indicates that different cell types are <italic>selectively</italic> at risk for developing tau pathology. Thus, understanding why all neurons are not equally susceptible to pathogenic tau is essential for identifying mechanisms underpinning disease pathobiology, and developing new treatment strategies.</p><p id="Par3">Selective neuronal vulnerability to disease is complex, resulting from many intrinsic and extrinsic factors [<xref ref-type="bibr" rid="CR6">6</xref>]. The ability to collectively study multiple deterministic factors pre-symptomatically has posed a real problem for dissecting selective vulnerability; however, animal models of disease like <italic>Drosophila</italic> have proven invaluable for recapitulating human disease symptoms in a low cost and genetically tractable system [<xref ref-type="bibr" rid="CR7">7</xref>]. Fly tauopathy models demonstrate that selective vulnerability is multi-faceted, involving differential distribution of tau-modifying kinases and phosphatases across different neuronal classes [<xref ref-type="bibr" rid="CR8">8</xref>], and the importance of primary neurotransmitter systems [<xref ref-type="bibr" rid="CR9">9</xref>]. However, many previous studies analysed tau expression in heterogenous classes of neurons, where pathogenic phenotypes represent an average of disease phenotypes over several cell types, and do not suppress tau expression during development rendering it difficult to separate developmental tau phenotypes from those acquired over lifespan [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par4">Addressing these issues, we used a collection of <italic>Drosophila</italic> lines using the Split-GAL4 intersectional strategy to target gene expression to small, precisely defined classes of neurons in the <italic>Drosophila</italic> ventral nervous system (VNS) [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. These neuronal populations represent single-neuron types, part of developmental lineages produced by single neuronal precursor cells, and represent functional modules within the central nervous system (CNS) serving specific behavioural functions and sharing common attributes of morphology, transcriptional profiles and neurotransmitter type [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. This refined toolset offers unprecedented resolution to study tauopathy. Temporally, driver lines restrict transgene expression to postmitotic adult neurons. Spatially, tau expression is narrowly restricted to single-neuron types. Further, the small number of labelled neurons (4&#x02013;20 cells) allows us to resolve subcellular structures and compartments. Lastly, tau expression within specific neurons, in an otherwise normal nervous system, ensures we are analysing primary pathological events only.</p><p id="Par5">Using a subset of available genetic lines, we undertook an unbiased screen of the effects of the highly-phosphorylated human tau isoform, hTau<sup>0N3R</sup>, to identify neuron types demonstrating vulnerability or resilience to tau as defined by unambiguous criteria: the degree and extent of cellular degeneration. Our model recapitulated previously reported typical age-dependent tau phenotypes, including loss of synaptic terminals, tau mislocalisation into dendrites, and beading and blebbing of neuronal processes containing tau accumulates [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. We found tau expression in different neuron types produces a spectrum of pathological effects, demonstrating that fly VNS neurons are <italic>differentially vulnerable</italic> to tau pathology. Examination of tau-dependent pathogenic mechanisms (e.g., localisation and phosphorylation) and mechanisms downstream of tau (e.g., vesicular and mitochondrial trafficking) highlight the heterogeneity of neuron type specific responses to tau when examined at single-cell resolution.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Fly genetics and maintenance</title><p id="Par6">SplitGAL4 driver lines (Fig. <xref rid="MOESM1" ref-type="media">S1</xref>; Table <xref rid="MOESM1" ref-type="media">S1</xref>) drove expression of the highly-phosphorylated and toxic human tau isoform, 0N3R (hTau<sup>0N3R</sup>), in postmitotic neurons in the adult <italic>Drosophila melanogaster</italic> VNS (Janelia FlyLight Project, [<xref ref-type="bibr" rid="CR11">11</xref>]). Eight neuron types were selected from a larger screen of 24 for having clear, tau-mediated phenotypes without problematic GAL4 driver expression issues (e.g., no larval brain expression (Fig. <xref rid="MOESM1" ref-type="media">S2</xref>), all drivers on in pupal brains at stage P8 (yellow-eyed, [<xref ref-type="bibr" rid="CR17">17</xref>]) of metamorphosis (Fig. <xref rid="MOESM1" ref-type="media">S3</xref>), and all drivers showing continued expression past 3wks post-eclosion). Crosses were maintained at 18&#x02009;&#x000b0;C and adults moved to 25&#x02009;&#x000b0;C post-eclosion for aging. Flies expressing LacZ &#x003b2;-Galactosidase (LacZ, Exelixis, Inc.) were used as controls for protein overexpression. Neuron morphology was revealed by co-expression of membrane-bound GFP (UAS-mCD8GFP). For mechanistic analysis of tau pathology, hTau<sup>0N3R</sup> or LacZ were co-expressed with the UAS-reporter lines, mitoGFP, for labelling mitochondria [<xref ref-type="bibr" rid="CR18">18</xref>], and nSyb-GFP, for labelling synaptic vesicles transported along axons to synaptic terminals [<xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec4"><title>Tissue preparation and immunohistochemistry</title><p id="Par7">Adult female VNSs were dissected at 0 (0wks) and 21 days (3wks) post-eclosion. Dissections, tissue preparation and immunostaining were performed as previously detailed [<xref ref-type="bibr" rid="CR20">20</xref>]. Primary antibodies used were: (1:1000) chicken anti&#x02010;GFP (Invitrogen-Molecular Probes, Cat. no. A10262), (1:15,000) rabbit anti&#x02010;hTau (Agilent- DAKO, Cat. no. A002401-2), (1:125) mouse anti-LacZ (J1E7, DSHB); (1:1000) mouse anti-phospho-Tau (Ser202, Thr205) antibody (AT8, Fisher, Cat. no. 10599853). Relevant secondary antibodies were used at (1:500). Images were acquired with a Zeiss LSM710 confocal microscope. For mechanistic analyses, identical image acquisition parameters were used.</p></sec><sec id="Sec5"><title>Blind scoring of phenotypic severity</title><p id="Par8">Neuronal morphology was scored blind to treatment (e.g., with or without hTau<sup>0N3R</sup> and timepoint, <italic>n</italic>&#x02009;=&#x02009;3&#x02013;10 per group) [<xref ref-type="bibr" rid="CR15">15</xref>]. Neurons were scored from 0 (no affect) to 3 (highly affected) using the presence or absence of previously described tau-mediated phenotypes (Criteria in Table <xref rid="MOESM1" ref-type="media">S2</xref>). Average Severity Score was calculated for each group.</p></sec><sec id="Sec6"><title>Data and statistical analyses</title><p id="Par9">Images were contrast&#x02010;enhanced as necessary and analysed in ImageJ (<ext-link ext-link-type="uri" xlink:href="http://rsbweb.nih.gov/ij/">http://rsbweb.nih.gov/ij/</ext-link>). Fluorescence intensity (i.e., levels) is displayed as Corrected total cell fluorescence (CTCF), where CTCF&#x02009;=&#x02009;Integrated Density - (Area of selected cell x Mean fluorescence of background readings) [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Mitochondrial number and volume were analysed using Imaris v10.0.1 (Oxford Instruments). Statistical analyses were performed with GraphPad Prism v9.1.0 (GraphPad Software, Inc., San Diego, CA). Statistical tests were selected based on data meeting requirements for homoscedasticity and normality for use of parametric tests; where requirements were not met, non-parametric tests were used. See Table <xref rid="MOESM1" ref-type="media">S3</xref> for details of statistical tests used and results of all comparisons. Samples were not analysed in a randomized manner. No statistical methods were used to determine sample size. No animals were excluded from analysis. No blinding was used in our assays except in blind scoring of phenotypic severity across neuron types.</p></sec></sec><sec id="Sec7" sec-type="results"><title>Results</title><sec id="Sec8"><title>Neuronal morphology reveals single-neuron types are differentially vulnerable to tau pathology</title><p id="Par10">To study the impact of tau expression on neuronal morphology, the 0N3R isoform of human tau (hTau<sup>0N3R</sup>) was co-expressed with membrane bound GFP (mCD8-GFP). The particular hTau<sup>0N3R</sup>-expressing genetic line used here was chosen as our lab have extensively studied this isoform and shown it to be constitutively highly phosphorylated in vivo and found that it induces visible degenerative phenotypes [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]. Since each neuron type has stereotypical morphology, anatomical changes (shape, size, membrane blebbing, dendritic and synaptic morphology/loss) can be easily detected. Detailed anatomical descriptions for neuron subtypes examined here are published [<xref ref-type="bibr" rid="CR20">20</xref>] (Table <xref rid="MOESM1" ref-type="media">S1</xref>). Our model recapitulated typical age-dependent tau phenotypes including loss of synaptic terminals, mislocalisation of tau into dendrites, and beading and blebbing of neuronal processes containing tau accumulates [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Blind Scoring (Fig. <xref rid="Fig1" ref-type="fig">1A</xref>) of morphology found that whilst tau expression impacted all neurons, the severity of effects represents a spectrum of pathology with some more affected than others (Fig. <xref rid="Fig1" ref-type="fig">1B</xref>). Despite differences across neuron types, responses of the same neuron type were consistent across replicates, exhibiting comparable defects over the same timeframe. Generally, tau expressing neurons fell into two broad categories: (i) <italic>resilient</italic> neurons exhibiting only minor defects at 0wks without significant progressive deterioration by 3wks (neurons types: 1A, 7B&#x003b1;, 19B&#x003b2;), and (ii) <italic>vulnerable</italic> neurons exhibiting early onset and significant defects (neuron types: 10B&#x003b2;, 12A, 19A&#x003b1;, 6A and B). Vulnerable neurons demonstrated either an age-dependent worsening of tau-mediated phenotypes over time (6A, B) or an early severe phenotype at 0wks that plateaued by 3wks (10B&#x003b2;, 12A, 19A&#x003b1;).<fig id="Fig1"><label>Fig. 1</label><caption><title>Neuron types in the <italic>Drosophila</italic> ventral nerve cord are differentially vulnerable to tau-mediated toxicity.</title><p><bold>A</bold> Graph of morphological severity scores from blind scoring of images at 0- and 3-wks post eclosion. hTau<sup>0N3R</sup> was expressed in different neuron types and blind scoring of cellular morphology was used to determine neuron vulnerability to hTau<sup>0N3R</sup>-mediated phenotypes. <bold>B</bold> Neuronal vulnerability to tau-mediated toxicity is a spectrum, with some neuron types being relatively more affected (vulnerable types) than others (resilient types). The most resilient neuron type was 19B&#x003b2;, whereas 6A was the type most vulnerable to tau-mediated toxicity.</p></caption><graphic xlink:href="41398_2025_3342_Fig1_HTML" id="d33e440"/></fig></p><sec id="Sec9"><title>Most vulnerable type, 6A</title><p id="Par11">6A neurons are GABAergic components of the circuits regulating sensory feedback during flight [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Our driver labels 6A only in the prothoracic neuromere (t1). In t1, 6A neurons project into dorsal neuropil forming extensive, primarily dendritic arborisations before sending a primary axonal projection into t2 to synapse onto downstream targets (Table <xref rid="MOESM1" ref-type="media">S1</xref>). Here, 6A neurons were the most severely affected with the highest average degenerative score at 3wks.</p><p id="Par12">At 0wks, control neurons (Fig. <xref rid="Fig2" ref-type="fig">2A</xref>) appear normal and hTau<sup>0N3R</sup>-expressing neurons (Fig. <xref rid="Fig2" ref-type="fig">2B</xref>) show some axon defasciculation (Fig. <xref rid="Fig2" ref-type="fig">2B</xref>, arrowhead) and other moderate early signs of degeneration, including membrane swellings in axons, dendrites and synaptic boutons. At 3wks, control 6A neurons (Fig. <xref rid="Fig2" ref-type="fig">2C</xref>) generally appeared normal with only mild age-related phenotypes including some fragmentation in dendrites and axons and some axon defasciculation. In contrast, hTau<sup>0N3R</sup>-expressing 6A neurons (Fig. <xref rid="Fig2" ref-type="fig">2D</xref>) showed severe morphological degeneration including fragmentation of defasciculated axons (Fig. <xref rid="Fig2" ref-type="fig">2D</xref>, arrowhead), axon thinning and fragmented synaptic boutons with loss of distal synaptic regions (Fig. <xref rid="Fig2" ref-type="fig">2E</xref>, asterisk), and shortening and swelling of proximal axonal compartments (Fig. <xref rid="Fig2" ref-type="fig">2I</xref>, yellow arrowhead).<fig id="Fig2"><label>Fig. 2</label><caption><title>hTau<sup>0N3R</sup> expression in the vulnerable 6A neurons causes degeneration in 3wk old adult flies, but not in the most resilient 19B&#x003b2; neurons.</title><p><bold>A</bold> Control 6A neurons at 0wks appear normal. <bold>B</bold> hTau<sup>0N3R</sup>-expressing 6A neurons at 0wks show some moderate signs of degeneration, including defasciculation of axonal processes (arrowhead). <bold>C</bold> Control 6A neurons at 3wks show some signs of age-dependent degeneration like axonal defasciculation but are otherwise normal. D. hTau<sup>0N3R-</sup>expresing 6A neurons at 3wks however show obvious neuronal degeneration. These neurons exhibit many of the classic features of tau toxicity: degeneration of defasciculated axons (<bold>D</bold>, arrowhead), axon thinning and fragmented synaptic terminals <bold>E</bold>, extracellular tau where cellular membranes have degenerated at 3wks (<bold>F</bold>, arrow), tau mislocalisation into dendrites over time <bold>G</bold>, and tau accumulation and change in appearance from continuous to beaded/fragmented over time <bold>H</bold>, shortening of and swellings in proximal axonal compartment (<bold>I</bold>, yellow arrowhead), Asterisks (*) highlight loss of terminal synaptic regions at 3wks. By contrast, age matched resilient 19B&#x003b2; neurons <bold>J,</bold>
<bold>K</bold> show little evidence of these features. Neuron morphology between control <bold>J</bold> and hTau<sup>0N3R</sup> expressing <bold>K</bold> neurons are not dissimilar. hTau<sup>0N3R</sup> is confined to large axonal compartments and there is little to no tau mislocalisation into dendritic compartments <bold>L</bold>.</p></caption><graphic xlink:href="41398_2025_3342_Fig2_HTML" id="d33e547"/></fig></p></sec><sec id="Sec10"><title>Most resilient type, 19B&#x003b2;</title><p id="Par13">19B&#x003b2; neurons are cholinergic premotor flight interneurons [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Our driver labels only 19B&#x003b2; neurons in the mesothoracic neuromere (t2). In t2, 19B&#x003b2; neurons enter the neuropil dorsally at the posterior margin of the neuromere and project medially crossing the midline at the posterior margin of the t2 neuropil (Table <xref rid="MOESM1" ref-type="media">S1</xref>). With the exception of a small dendritic region, the synaptic region of this neuron type is axo-dendritic, meaning a mix of inputs and outputs. Here, 19B&#x003b2; neurons were least affected with the lowest average degenerative severity scores at both 0- and 3wks. At 0wks, hTau<sup>0N3R</sup>-expressing neurons looked normal, resembling controls, with little sign of any of the morphological changes described for vulnerable neurons. At 3wks, all control and tau-expressing neurons continued to look normal (Fig. <xref rid="Fig2" ref-type="fig">2J, K</xref>), with the exception of single outliers in both categories: one control neuron showed possible signs of axonal degeneration and one tau-expressing neuron showed some abnormal tau accumulation in fine processes. This data shows that the resilient neurons are resistant to developing pathology following expression of human tau, even if the tau has been expressed for several weeks.</p></sec></sec><sec id="Sec11"><title>Tau-dependent mechanisms for neuronal vulnerability</title><sec id="Sec12"><title>Appearance and cellular localization of tau</title><p id="Par14">Generally, hTau<sup>0N3R</sup> accumulated over time (0- vs. 3wks) in all neuron types examined and its distribution throughout the neuron changed with time with tau moving from axons into more distal and finer neuronal processes. However, two common features were associated with vulnerability: (i) greater accumulation of tau within fine processes and mislocalisation into dendrites over time and (ii) a change in the appearance over time of hTau<sup>0N3R</sup> from smooth and continuous to a fragmented form that is usually indicative of abnormal tau accumulation [<xref ref-type="bibr" rid="CR15">15</xref>]. The fragmented appearance of tau alone was not correlated with degeneration if tau was confined to the main processes. However, the appearance of tau in more finer processes, often in aged neurons, was correlated with greater degeneration throughout the entire neuron in regions where tau is more fragmented.</p><p id="Par15">In the most vulnerable 6A neurons at 0wks (Fig. <xref rid="Fig2" ref-type="fig">2B&#x02019;</xref>) there were low levels of hTau<sup>0N3R</sup> tau in dendrites (Fig. <xref rid="Fig2" ref-type="fig">2F</xref>), and some beaded tau in long axons although most tau is smooth and continuous (Fig. <xref rid="Fig2" ref-type="fig">2H</xref>). At 3wks, hTau<sup>0N3R</sup> in 6A neurons (Fig. <xref rid="Fig2" ref-type="fig">2D&#x02019;</xref>) had mislocalised into dendrites and the appearance of tau in this compartment is small and fragmented (Fig. <xref rid="Fig2" ref-type="fig">2F</xref>). In the proximal axonal compartment, tau has changed over time from smooth and continuous to fragmented in appearance (Fig. <xref rid="Fig2" ref-type="fig">2H</xref>). In addition to visible loss of the most distal pre-synaptic regions (Fig. <xref rid="Fig2" ref-type="fig">2F</xref>, asterisk), this region also contains &#x0201c;extracellular&#x0201d; tau which are neuronal structures that are hTau positive but mCD8GFP negative (Fig. <xref rid="Fig2" ref-type="fig">2F</xref>, arrow) and thus resemble ghost tangles [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par16">In the least affected type, 19B&#x003b2;, tau appears as small, beaded aggregates at 0wks confined to larger axon segments and rarely observed in finer processes. At 3wks, tau aggregates remained mainly in larger axon segments, with little mislocalisation of tau into finer dendritic processes (Fig. <xref rid="Fig2" ref-type="fig">2L</xref>). Although tau is present in this neuron type and is beaded in some places, it is largely smooth in appearance and does not take on a beaded fragmented appearance. These neurons remain morphologically normal, looking like controls even at 3wk (Fig. <xref rid="Fig2" ref-type="fig">2K</xref>).</p><p id="Par17">In other resilient types, a similar pattern of tau distribution is observed. In 1A neurons small accumulates of tau are restricted to the main axons with little in dendrites and finer processes at both 0 and 3wks. A correlation between the presence of fragmented tau and morphological degeneration is seen in 7B&#x003b1; neurons classified as &#x0201c;resilient&#x0201d; but showing some insightful intermediary phenotypes. At 0wks, tau in 7B&#x003b1; is fragmented but is confined to the main processes with neuron membranes showing some signs of fragmentation in finer processes. At 3wks, there is a variable phenotype where in neurons with generally normal morphology, tau is smooth and continuous in long axons with some fragmentation in finer processes (Figure <xref rid="MOESM1" ref-type="media">S5</xref>). When tau is fragmented throughout both long axons and finer processes there are early signs of degeneration. In such 7B&#x003b1; neurons, localised degeneration is seen and correlated with the colocalization of beaded/fragmented tau.</p></sec><sec id="Sec13"><title>The severity of morphological phenotypes does not correlate with total hTau levels</title><p id="Par18">To determine if morphological severity across neuron types was the result of varying hTau<sup>0N3R</sup> expression levels, we quantified hTau<sup>0N3R</sup> levels at 0- and 3wks in all eight neuron types. At 0wks all neuron types had comparable levels of hTau<sup>0N3R</sup> expression [F(7,13.61)&#x02009;=&#x02009;1.704; <italic>P</italic>&#x02009;=&#x02009;0.19] (Fig. <xref rid="Fig3" ref-type="fig">3A</xref>). At 3wks there were significant differences in total hTau<sup>0N3R</sup> levels between neuron types [F (7,33)&#x02009;=&#x02009;11.37; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001]; however, post-hoc Tukey analysis found no clear relationship between phenotypic severity and total tau levels (Fig. <xref rid="Fig3" ref-type="fig">3B</xref>). To further investigate the relationship between total tau levels and degeneration, degenerative severity scores for resilient and vulnerable neurons at 3wks was compared with total hTau<sup>0N3R</sup> levels at 3wks. This also showed no correlation (r&#x02009;=&#x02009;&#x02212;0.10, <italic>P</italic>&#x02009;=&#x02009;0.80) suggesting degenerative severity is not caused by hTau<sup>0N3R</sup> levels (Fig. <xref rid="MOESM1" ref-type="media">S4</xref>). This is evident when comparing tau levels across resilient and vulnerable neuron types; for example, hTau<sup>0N3R</sup> levels are significantly greater in resilient 19B&#x003b2; neurons than in vulnerable 6B neurons (Fig. <xref rid="Fig3" ref-type="fig">3B</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Tau dependent mechanisms for vulnerability.</title><p>An increase in phosphorylated tau (p-tau) levels, but not total tau, over time correlates with neuronal vulnerability. <bold>A</bold> Levels of total tau between all neuron subtypes does not significantly differ at 0wks (<italic>P</italic>&#x02009;=&#x02009;0.19)(<italic>n</italic>&#x02009;=&#x02009;5&#x02013;8 per group). <bold>B</bold> At three weeks there is a significant difference in tau levels between neuron subtypes (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001)(<italic>n</italic>&#x02009;=&#x02009;3&#x02013;8 per group); however, there is no clear correlation between phenotypic severity and tau levels across resilient or vulnerable neuron types. Data with the same letters are not significantly different (<italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05). <bold>C</bold> There are significant differences in p-tau (AT8) levels at 3wks compared to 0wks for some vulnerable neuron subtypes, but not resilient types. The vulnerable neurons, 12 and 19A, show a significant increase in p-tau levels over time; however, 10B shows a significant decrease and 6B no change. Whilst 6A neurons show a trend towards increase of p-tau levels over time, this is not significant post correction for multiple comparisons (<italic>P</italic>&#x02009;=&#x02009;0.38)(<italic>n</italic>&#x02009;=&#x02009;3&#x02013;14 per group). Asterisks denote significance as follows: *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <bold>D</bold> Maximum intensity projections (MIPs) of p-tau expression in vulnerable 6A neurons at 3wks are shown as heatmaps where pixel intensity is correlated with a colour scale. Over time, p-tau expression can visually be seen to accumulate and spread to more distal neuronal compartments in the vulnerable neuron type 6A. Arrowheads indicate hotspots of p-tau accumulation. Where p-tau is acutely localised to soma and proximal axons at 0wks, there are many more p-tau hotspots in distal axons and presynaptic areas at 3wks. <bold>E</bold> Phospho-tau labels a subset of total tau (DAKO). Regions within perforated lines highlight differences in total tau and p-tau localisation in finer processes, which have been magnified in <bold>F,</bold>
<bold>G</bold>. <bold>F</bold> Higher magnification images of the dendrites showing that hTau<sup>0N3R</sup> has spread into the dendrites at 3wks; however, there is little p-tau spread (AT8). <bold>G</bold> Higher resolution image of 6A distal axon terminals and pre-synaptic regions show p-tau has not penetrated the most distal cellular regions.</p></caption><graphic xlink:href="41398_2025_3342_Fig3_HTML" id="d33e734"/></fig></p></sec><sec id="Sec14"><title>Vulnerable neurons generally show significant age-dependent increase in hTau phosphorylation</title><p id="Par19">With total tau levels not appearing to be the cause of vulnerability, we next explored the role of tau phosphorylation in differential vulnerability as several studies, including those from our lab, have previously implicated tau phosphorylation in tau toxicity [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. We examined tau phosphorylation at the AT8 epitope site (pS202/pT205) in hTau<sup>0N3R</sup>, a site associated with AD pathology [<xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR30">30</xref>]. We examined phospho-tau levels at AT8 sites (p-tau) across our eight neuron times at two timepoints (0 and 3-wks post-eclosion). A two-way ANOVA was used to analyse the effects of neuron-type and time on p-tau levels (i.e., corrected AT8 fluorescence), and found a significant interaction between neuron-type and time (F (7, 71)&#x02009;=&#x02009;16.36, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). To examine the specific relationships within this interaction more closely, Simple Main Effects Analysis was used and found that neuron-type has a statistically significant effect on p-tau levels (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), and that time has a significant effect on p-tau levels (<italic>P</italic>&#x02009;=&#x02009;0.0042). To better understand which of these factors could best explain our noted neuronal vulnerability, further analysis of this complex data was carried out. Whilst different neuron types at a single timepoint show many significant differences in their p-tau levels (Fig. <xref rid="MOESM1" ref-type="media">S6A, B</xref>), p-tau levels do not correlate with time-matched morphological severity scores at either 0wks (r&#x02009;=&#x02009;0.69, <italic>P</italic>&#x02009;=&#x02009;0.06) (Fig. <xref rid="MOESM1" ref-type="media">S6C</xref>) or 3wks (r&#x02009;=&#x02009;0.23, <italic>P</italic>&#x02009;=&#x02009;0.58) (Fig. <xref rid="MOESM1" ref-type="media">S6D</xref>). Thus, neuron type at a particular time point cannot provide an explanation for the observed vulnerability. However, post-hoc analysis of p-tau levels for the same neuron type across time (0wks vs. 3 wks), found that resilient types (1A, 19B&#x003b2; or 7B&#x003b1;) do not show significant changes over time, but some vulnerable neurons do (Fig. <xref rid="Fig3" ref-type="fig">3C</xref>). 19 and 12A neurons show significant increases and 10B a significant decrease. 6A neurons show an increase in p-tau levels that is not significant post correction for multiple comparisons. Thus, the change in p-tau levels over time for the same neuron type provides some explanation for the observed vulnerability.</p><p id="Par20">A visual examination of p-tau accumulation and localisation in the vulnerable 6A neurons, shows how p-tau accumulates first in cell bodies and proximal axons at 0wks before accumulating and localising to more distal regions with time (Fig. <xref rid="Fig3" ref-type="fig">3D</xref>). However, p-tau labelled only a subset of total hTau immunoreactivity, being notably absent from finer neuronal processes of dendritic compartments and the most distal synaptic regions (Fig. <xref rid="Fig3" ref-type="fig">3E&#x02013;G</xref>). In the most vulnerable 6A neurons, whilst there is a significant amounts of total tau at 3wks in the dendritic compartment, very little of it is p-tau positive (Fig. <xref rid="Fig3" ref-type="fig">3F</xref>). In the pre-synaptic regions of this neuron, p-tau is present but unlike total-tau is not present in the finer, most-distal processes (Fig. <xref rid="Fig3" ref-type="fig">3G</xref>).</p><p id="Par21">This data collectively implies that it is not the amount of tau within a neuron but its accumulation of p-tau with time that plays a role in determining its vulnerability to degeneration.</p></sec></sec><sec id="Sec15"><title>Mechanisms downstream of tau contributing to vulnerability</title><sec id="Sec16"><title>Vesicular trafficking</title><p id="Par22">Accumulation of synaptic vesicles along axons is a hallmark of defective axon transport [<xref ref-type="bibr" rid="CR23">23</xref>]. Therefore, the effects of hTau<sup>0N3R</sup> on vesicular trafficking were studied by examining area covered by GFP-labelled synaptic vesicles (nSyb-GFP) across individual neuron-types to determine if this area changed when compared to control neurons expressing the innocuous protein, LacZ (control). Given that neuron size can vary, only measures of area (control versus hTau<sup>0N3R</sup>) for a neuron-type were compared using unpaired t-tests. Comparisons for all eight neurons at 3wks are plotted on the same graph with neuron type arranged from most resilient to most vulnerable on the x-axis to help visualise any relationship with vulnerability (Fig. <xref rid="Fig4" ref-type="fig">4A</xref>). At 3wks, resilient neuron types (19B&#x003b2;, 1A, 7B&#x003b1;) showed no significant differences in area covered by GFP-labelled vesicles between neurons expressing LacZ or hTau<sup>0N3R</sup>, after correcting for multiple comparisons (Fig. <xref rid="Fig4" ref-type="fig">4A</xref>). In vulnerable neurons, 12A (t<sub>(7)</sub>&#x02009;=&#x02009;4.9; <italic>P</italic>&#x02009;=&#x02009;0.002), 6B (t<sub>(7)</sub>&#x02009;=&#x02009;4.1; <italic>P</italic>&#x02009;=&#x02009;0.005) and 6A (t<sub>(10)</sub>&#x02009;=&#x02009;6.8; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) showed significant decreases in area covered by labelled vesicles when hTau<sup>0N3R</sup> was present. 10B&#x003b2; and 19A&#x003b1; neurons showed no difference.<fig id="Fig4"><label>Fig. 4</label><caption><title>Neurons that show vesicular trafficking defects are vulnerable types.</title><p><bold>A</bold> The vulnerable neurons 12A, 6B and 6A all show significantly decreased area covered by GFP labelled synaptic vesicles (nSyb-GFP) in tau expressing neurons compared to control at 3wks. This suggests the presence of trafficking defects in these neuron types when hTau<sup>0N3R</sup> is present. (<italic>n</italic>&#x02009;=&#x02009;3&#x02013;8 per group) <bold>B</bold> Maximum intensity projections (MIPs) of nSyb-GFP expression in vulnerable 6A neurons at 3wks are shown as heatmaps of pixel intensity correlated with colour scale for control (LacZ-expressing) and hTau<sup>0N3R</sup>-expressing neurons. Heatmaps of nSyb-GFP expression in 6A neurons reveal that whilst there are evenly distributed hotspots of nSyb-GFP accumulation (red) in control neurons, these are lacking in hTau<sup>0N3R</sup>-expressing neurons. Yellow boxes highlight the distal pre-synaptic regions which most clearly show differences in nSybGFP localisaion, and arrowheads point to hot spots. <bold>C</bold>&#x02013;<bold>F</bold> Closer examination of the most distal pre-synaptic regions of 6A neurons (regions enclosed by yellow boxes in B) found that whilst nSyb-GFP levels do not change between control and hTau<sup>0N3R</sup> expressing neurons (<bold>C</bold>), there is a significant decrease in area covered by nSyb-GFP when tau is overexpressed (<bold>D</bold>)(<italic>n</italic>&#x02009;=&#x02009;8&#x02013;16 per group). More specifically this can be explained by significant reductions in the number (<bold>E</bold>) and size (<bold>F</bold>) of nSyb-GFP hotspots in the distal pre-synaptic regions of hTau<sup>0N3R</sup>-expressing neuron (<italic>n</italic>&#x02009;=&#x02009;8&#x02013;16 per group). <bold>G</bold> Mitochondrial trafficking at 3wks in control and hTau<sup>0N3R</sup>-expressing vulnerable 6A neurons was visualised using mito-GFP to label mitochondria. Enlarged regions of control and tau-expressing neurons are shown for axons (1), soma (2), dendrites (3) and synapses (4) of 6A neurons at 3wks. Where control neurons show similarly shaped mitochondria that are evenly distributed, hTau<sup>0N3R</sup>-expressing neurons show evidence of trafficking defects. Arrowheads highlight irregularly shaped mitochondria and clumping of mitochondria in axonal regions (2). There are fewer mitochondria in the dendrites (3) and distal synaptic regions (4) of tau-expressing neurons and mitochondria accumulate in the soma (2). <bold>H</bold> There is a significant increase in the amount of mitoGFP that accumulates in the soma of hTau<sup>0N3R</sup> expression 6A neurons compared to controls at 3wks, which is consistent with mitochondrial trafficking defects (<italic>n</italic>&#x02009;=&#x02009;8&#x02013;10 per group). Statistical difference is noted with asterisks as follows: ns, not significant; *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001.</p></caption><graphic xlink:href="41398_2025_3342_Fig4_HTML" id="d33e916"/></fig></p><p id="Par23">Closer examination of vesicular trafficking in vulnerable 6A neurons at 3wks found that while total levels of GFP-labelled vesicle across the entire neuron were not different between control and hTau<sup>0N3R</sup>-expressing neurons (t<sub>(10)</sub>&#x02009;=&#x02009;1.8; <italic>P</italic>&#x02009;=&#x02009;0.11)(Fig. <xref rid="MOESM1" ref-type="media">S7C</xref>), heatmaps of maximum intensity projections (MIP) of GFP-labelled vesicle expression reveal evenly distributed hotspots of vesicle accumulation in control neurons that are missing when hTau<sup>0N3R</sup> is present (Fig. <xref rid="Fig4" ref-type="fig">4B</xref>). Given the noticeable lack of hot spots in the most distal pre-synaptic regions of the 6A neurons, this area was examined at 3wks (Fig. <xref rid="Fig4" ref-type="fig">4C&#x02013;F</xref>). Levels of GFP-labelled vesicles between control and hTau<sup>0N3R</sup> expressing neurons were not significantly different across pre-synaptic regions (t<sub>(22)</sub>&#x02009;=&#x02009;1.2; <italic>P</italic>&#x02009;=&#x02009;0.26); but, area covered by labelled vesicles was significantly reduced (t<sub>(21)</sub>&#x02009;=&#x02009;2.5; <italic>P</italic>&#x02009;=&#x02009;0.02) (Fig. <xref rid="Fig4" ref-type="fig">4C, D</xref>). In this region, size (t<sub>(22)</sub>&#x02009;=&#x02009;6.3; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) and number t<sub>(22)</sub>&#x02009;=&#x02009;4.2; <italic>P</italic>&#x02009;=&#x02009;0.0003) of hotspots were significantly reduced when hTau<sup>0N3R</sup> was present (Fig. <xref rid="Fig4" ref-type="fig">4E, F</xref>).</p><p id="Par24">To determine timing of vesicular trafficking defects, we compared the area covered by labelled vesicles in control and hTau<sup>0N3R</sup>-expressing neurons for a given neuron type at 0wks using unpaired t-tests. Although 1A neurons showed an increase in area and 6B a decrease, neither were significant post correction for multiple comparisons (Fig. <xref rid="MOESM1" ref-type="media">S8</xref>).</p></sec><sec id="Sec17"><title>Mitochondrial trafficking</title><p id="Par25">Tau over-expression causes synaptic dysfunction as a consequence of fewer functional mitochondria [<xref ref-type="bibr" rid="CR24">24</xref>]. To see if mitochondrial trafficking defects correlated with morphological degeneration, the effects of hTau<sup>0N3R</sup> on localisation of GFP-labelled mitochondria (mitoGFP) [<xref ref-type="bibr" rid="CR18">18</xref>] was examined in the most vulnerable 6A neurons. At 3wks, there were noticeable differences in the subcellular appearance of mitochondria between control and tau expressing neurons (Fig. <xref rid="Fig4" ref-type="fig">4G</xref>). Mitochondria in axons are thin and tubular in control neurons and more globular when tau is present (Fig. <xref rid="Fig4" ref-type="fig">4G-1</xref>). Tau-expressing neurons showed greater mitochondrial accumulation in soma (Fig. <xref rid="Fig4" ref-type="fig">4G-2</xref>), with fewer and smaller mitochondria in dendrites (Fig. <xref rid="Fig4" ref-type="fig">4G-3</xref>) and distal presynaptic areas (Fig. <xref rid="Fig4" ref-type="fig">4G-4</xref>). Quantification of mitoGFP accumulation in the soma of 6A neurons found a significant increase in mitoGFP fluorescence in hTau<sup>0N3R</sup> expressing neurons when compared to control neurons at 3wks (t<sub>(16)</sub>&#x02009;=&#x02009;2.4; <italic>P</italic>&#x02009;=&#x02009;0.03)(Fig. <xref rid="Fig4" ref-type="fig">4H</xref>), with accumulation in soma evident as early as 0wks (t<sub>(14)</sub>&#x02009;=&#x02009;3.1; <italic>P</italic>&#x02009;=&#x02009;0.008)(Fig. <xref rid="MOESM1" ref-type="media">S9E</xref>). When total number and total volume of mitochondria across the entire neuron were quantified for hTau<sup>0N3R</sup>-expressing and control 6A neurons at 0 and 3wks, although trends were noted toward decrease and increase, respectively, these were not significant (Fig. <xref rid="MOESM1" ref-type="media">S9A&#x02013;D</xref>).</p></sec></sec></sec><sec id="Sec18" sec-type="discussion"><title>Discussion</title><p id="Par26">This work demonstrates the utility of a tractable in vivo model to study neuronal vulnerability in homogenous neuronal types with subcellular resolution. With this model we show that neurons of the fly CNS are differentially vulnerable to tau-mediated toxicity, thus highlighting the heterogenous nature of cellular responses to toxic proteins. The importance of innate factors in determining neuronal vulnerability to tau was recently reported in a single-cell RNA-sequencing study examining ~200 different neuron types [<xref ref-type="bibr" rid="CR31">31</xref>]. Favouring resolution over scale, we report parallel findings highlighting importance of innate factors in influencing vulnerability, but in a small selection of homogenous neurons.</p><p id="Par27">Having the advantage of analysing known neurons, we sought common features of vulnerability by collating information from the literature [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR20">20</xref>] with noted findings and patterns between our vulnerable and resilient neurons (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Amongst vulnerable neuron types, there were two phases of vulnerability when determined from morphological severity scores at 0 and 3wks: during process outgrowth and elaboration of postmitotic adult neurons (during late pupariation) [<xref ref-type="bibr" rid="CR32">32</xref>], and age-dependent (across lifespan post-eclosion). Differential effects of tau during these phases is not clear; but, variation between vulnerable neuron types suggests innate factors influence outcome. Roussarie et al. [<xref ref-type="bibr" rid="CR33">33</xref>] identified vulnerability modules associated with AD pathology involving processes like axogenesis, microtube organisation, regulation of synaptic plasticity and neurotransmitter secretion. Thus, the first phase of vulnerability during late pupariation, may be more susceptible to disruption of these processes than the second. Why phase of vulnerability varies across neurons could depend on how quickly tau becomes toxic within a particular neuron type. Differential expression of tau toxicity modifiers across resilient and vulnerable neuron types may explain this in part [<xref ref-type="bibr" rid="CR31">31</xref>]. Certainly, the outcome would be compounded by another factor&#x02014;which tau isoform is involved. Here we expressed 0N3R tau in our neurons, which is the foetal isoform expressed during neurogenesis and the isoform that predominantly accumulates in Pick&#x02019;s Disease [<xref ref-type="bibr" rid="CR34">34</xref>]. It is possible that some property of 0N3R may have facilitated a more disruptive role during the first phase of vulnerability in some neuron types. Whether 4R tau isoforms would produce the same pattern of vulnerability remains to be seen.<fig id="Fig5"><label>Fig. 5</label><caption><title>Summary of results and intrinsic characteristics of neurons examined in this study.</title><p>Collated data from the literature and this study describing all eight neuron subtypes examined here. The asterisks denote observed trends not significant post correction for multiple comparisons.</p></caption><graphic xlink:href="41398_2025_3342_Fig5_HTML" id="d33e1070"/></fig></p><p id="Par28">Whilst all resilient types were cholinergic, vulnerable types were GABAergic or cholinergic. It is difficult to correlate transmitter type with vulnerability given our small sample size; however, Praschberger et al. noted vulnerable and resilient neurons were of mixed transmitter types [<xref ref-type="bibr" rid="CR31">31</xref>]. Surprisingly, there also was no correlation between neuron function and vulnerability although neurons with high metabolic demands (i.e., flight associated) were expected to be more vulnerable [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par29">Mechanistically, morphological vulnerability correlated well with significant age-dependent increases in pathological tau phosphorylation at Ser<sup>202</sup> and Thr<sup>205</sup> (AT8) sites in the same single-neuron type. Whilst our resolution is novel, age-dependant tau hyperphosphorylation is supported by the literature [<xref ref-type="bibr" rid="CR36">36</xref>&#x02013;<xref ref-type="bibr" rid="CR38">38</xref>]. We also found phospho-tau levels vary across <italic>Drosophila</italic> cell types [<xref ref-type="bibr" rid="CR8">8</xref>], and show this occurs at more spatially refined levels perhaps indicative of differential expression of tau modifying kinases or phosphatases across single-neuron types.</p><p id="Par30">Vulnerability also correlated with vesicular trafficking defects which occur downstream of tau phosphorylation [<xref ref-type="bibr" rid="CR23">23</xref>]. However, the link between p-tau levels and vesicular trafficking is not fast as 19A&#x003b1; neurons showed an increase in p-tau levels over time without trafficking defects, while 6B neurons showed the opposite pattern of trafficking defects without increased p-tau. It is possible the increase in p-tau levels in 6B neurons occurred more rapidly and was missed, since 6B neurons had a high severity score and signs of vesicular trafficking defects at 0wks. Alternatively, hTau<sup>0N3R</sup> could be phosphorylated at a different sites affecting microtubule stability not explored here [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. The pathway leading to degeneration in 19A&#x003b1; neurons is less clear and does not seem to involve overt vesicular trafficking.</p><p id="Par31">In vulnerable 6A neurons, vesicular trafficking defects at 3wks extend to presynaptic regions where hTau<sup>0N3R</sup> presence results in smaller and reduced numbers of vesicular hotspots. This may be due to morphological defects or degeneration (e.g. shape and number of active zones) as the consequence of tau overexpression, but could be in part due to the effects of tau on acute vesicular localisation at presynaptic terminals [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. In the same region and timepoint, organelle trafficking issues are also observed. We noted in 6A neurons, differences in the appearance of mitochondria across subcellular compartments, and fewer mitochondria in presynaptic regions. Similar mitochondrial trafficking defects have been noted in the <italic>Drosophila</italic> neuromuscular junction with subsequent bioenergetic consequences for neuronal function, indicating this may represent a common mechanism of tau-mediated dysfunction [<xref ref-type="bibr" rid="CR24">24</xref>]. Interestingly, indications of mitochondrial trafficking issues are evident in 6A neurons at 0wks, before elevated p-tau levels and significant vesicular trafficking defects. Other studies have shown tau overexpression results in mitochondrial mislocalisation to the soma by disrupting kinesin-mediated anterograde transport whilst leaving dynein-mediated retrograde relatively undisturbed, and that this can occur without affecting vesicular transport [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. This temporal glimpse into cellular events in 6A suggests mitochondrial trafficking deficits may occur earlier in disease pathogenesis before vesicular trafficking defects and overt morphological degeneration, at least in some neurons.</p><p id="Par32">The appearance and mislocalisation of tau was another factor correlating with vulnerability. Tau was generally fragmented in regions correlating with morphological damage, which occurred with greater frequency in vulnerable neuron types. This supports the general belief that as tau becomes toxic, as with increased phosphorylation, it aggregates and causes degeneration. Whilst we cannot say that tau aggregates more in vulnerable neurons because we did not use aggregation-sensitive probes (e.g., Thioflavin T), the fragmentation of tau and appearance of beading on axonal processes is suggestive of tau accumulating as a precursor of aggregation. However, it should be noted that tau can cause degeneration even in the absence of filamentous aggregate formation in <italic>Drosophila</italic> [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]; therefore, while vulnerability could be caused by an increased propensity for tau to aggregate in vulnerable neuron types, it is possible that degeneration occurs without the need for aggregation.</p><p id="Par33">In vulnerable neurons, there was an age-dependent mislocalisation of tau into the finer neuronal processes of dendrites. Given that some surveyed neuron types lacked defined, purely dendritic regions suggests basic neuron anatomy (e.g. proximal-distal, continuous) may play some role in conferring vulnerability. The most affected neuron type, 6A, was polarised with large, purely dendritic regions; whereas, the most resilient,19B&#x003b2;, was mainly axo-dendritic. While not a fast rule, most vulnerable types were polarised (e.g., 6A, 19A&#x003b1;, 10B&#x003b2;) and most resilient axo-dendritic (19B&#x003b2;, 7B&#x003b1;). It is possible the effects of tau toxicity, such as mislocalisation of tau or organelles through microtubule dependent transport, have greater potential to damage cell types that must maintain overt cell polarity [<xref ref-type="bibr" rid="CR40">40</xref>]. However, the relationship between anatomy and vulnerability is more complex, since neurons can be polarised and resilient like 1A. Leng et al. [<xref ref-type="bibr" rid="CR43">43</xref>] found that morphology alone was insufficient to determine neuronal vulnerability as both excitatory large multipolar and pyramidal cells in the entorhinal complex were differentially affected in AD, rather vulnerability better correlated with the presence/absence of the gene RORB. This indicates in the very least, morphology must be coupled with a genetic propensity for vulnerability.</p><p id="Par34">This latter idea is key as differential gene expression establishes neuron identity and maintains it across lifespan [<xref ref-type="bibr" rid="CR44">44</xref>&#x02013;<xref ref-type="bibr" rid="CR46">46</xref>]. In fact, different neuron subtypes here can be differentiated by the expression of neuron subtype specific genes [<xref ref-type="bibr" rid="CR14">14</xref>]. Thus, each neuron has a unique molecular landscape, and a cell&#x02019;s capacity to cope with abnormal protein accumulation must be viewed in light of how custom contexts first determine if tau becomes dysfunctional, then, how the system deals with the ensuing stress [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR47">47</xref>&#x02013;<xref ref-type="bibr" rid="CR50">50</xref>]. In a simple scenario, vulnerability could arise from the presence/absence of tau modifying kinases and phosphatases within a neuron type; however, it is more likely to be the sum of many factors (e.g., levels of chaperone proteins facilitating aggregation, waste removal proteins, mechanisms for reducing oxidative stress, genes associated with neuron excitability or Ca<sup>2+</sup> homeostasis, etc.) [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR50">50</xref>].</p><p id="Par35">In the context of disease, evidence from mammalian and fly RNA-sequencing studies highlight cell-type specific transcriptional changes as the consequence of normal aging and in response to AD pathogenesis and progression [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. These divergent and evolving landscapes make it no surprise that different neuron subtypes fall along a vulnerability spectrum, or that vulnerable neuron types show variation in the cellular events preceding neurodegeneration. There may be many routes to the same end.</p><p id="Par36">Although we limited our analysis to a few tau-dependent mechanisms, our model facilitates study of a vast number of cellular processes given the plethora of available fly genetic tools. In future this model could elaborate a more holistic picture of the differential temporal and spatial events preceding neuronal degeneration in vulnerable and resilient neurons in AD and other neurodegenerative diseases.</p></sec><sec id="Sec19" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41398_2025_3342_MOESM1_ESM.pdf"><caption><p>Supplementary Figures and Tables</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41398-025-03342-2.</p></sec><ack><title>Acknowledgements</title><p>We thank Howard Hughes Medical Institute (Janelia Research Campus and Professor Jim Truman) for the use of their Split-GAL4 drivers. All other fly lines were obtained from the Bloomington Drosophila Stock Centre. This work was supported by funding to L.S. from Alzheimer&#x02019;s Society UK Junior Fellowship [grant number 315] and Alzheimer&#x02019;s Society UK Heather Corrie Fellowship [grant number 574].</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>LS conducted the experiments and analysis; LS, DS and AM designed the experiments and wrote the paper.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Data is available on request.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par37">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Mandelkow</surname><given-names>EM</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><article-title>Tau in Alzheimer&#x02019;s disease</article-title><source>Trends Cell Biol</source><year>1998</year><volume>8</volume><fpage>425</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9854307</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Mandelkow EM, Mandelkow E. Tau in Alzheimer&#x02019;s disease. Trends Cell Biol. 1998;8:425&#x02013;7.<pub-id pub-id-type="pmid">9854307</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>MG</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name></person-group><article-title>Tau protein pathology in neurodegenerative diseases</article-title><source>Trends Neurosci</source><year>1998</year><volume>21</volume><fpage>428</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9786340</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Spillantini MG, Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 1998;21:428&#x02013;33.<pub-id pub-id-type="pmid">9786340</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><name><surname>Lawler</surname><given-names>S</given-names></name><name><surname>Cuenda</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name></person-group><article-title>Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases</article-title><source>FEBS Lett</source><year>1997</year><volume>409</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">9199504</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 1997;409:57&#x02013;62.<pub-id pub-id-type="pmid">9199504</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>SE</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Flory</surname><given-names>J</given-names></name><name><surname>Damasio</surname><given-names>AR</given-names></name><name><surname>Van Hoesen</surname><given-names>GW</given-names></name></person-group><article-title>The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer&#x02019;s disease</article-title><source>Cereb Cortex</source><year>1991</year><volume>1</volume><fpage>103</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">1822725</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer&#x02019;s disease. Cereb Cortex. 1991;1:103&#x02013;16.<pub-id pub-id-type="pmid">1822725</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Arriagada</surname><given-names>PV</given-names></name><name><surname>Growdon</surname><given-names>JH</given-names></name><name><surname>Hedley-Whyte</surname><given-names>ET</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><article-title>Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer&#x02019;s disease</article-title><source>Neurology</source><year>1992</year><volume>42</volume><fpage>631</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1549228</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer&#x02019;s disease. Neurology. 1992;42:631&#x02013;9.<pub-id pub-id-type="pmid">1549228</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Mattsson</surname><given-names>N</given-names></name><name><surname>Schott</surname><given-names>JM</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>MR</given-names></name><name><surname>Zetterberg</surname><given-names>H</given-names></name></person-group><article-title>Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer&#x02019;s disease</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2016</year><volume>87</volume><fpage>1000</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">26746185</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Mattsson N, Schott JM, Hardy J, Turner MR, Zetterberg H. Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer&#x02019;s disease. J Neurol Neurosurg Psychiatry. 2016;87:1000&#x02013;4.<pub-id pub-id-type="pmid">26746185</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Sivanantharajah</surname><given-names>L</given-names></name><name><surname>Mudher</surname><given-names>A</given-names></name><name><surname>Shepherd</surname><given-names>D</given-names></name></person-group><article-title>An evaluation of <italic>Drosophila</italic> as a model system for studying tauopathies such as Alzheimer&#x02019;s disease</article-title><source>J Neurosci Methods</source><year>2019</year><volume>319</volume><fpage>77</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">30633936</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Sivanantharajah L, Mudher A, Shepherd D. An evaluation of <italic>Drosophila</italic> as a model system for studying tauopathies such as Alzheimer&#x02019;s disease. J Neurosci Methods. 2019;319:77&#x02013;88.<pub-id pub-id-type="pmid">30633936</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Grammenoudi</surname><given-names>S</given-names></name><name><surname>Kosmidis</surname><given-names>S</given-names></name><name><surname>Skoulakis</surname><given-names>EM</given-names></name></person-group><article-title>Cell type-specific processing of human Tau proteins in <italic>Drosophila</italic></article-title><source>FEBS Lett</source><year>2006</year><volume>580</volume><fpage>4602</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16875690</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Grammenoudi S, Kosmidis S, Skoulakis EM. Cell type-specific processing of human Tau proteins in <italic>Drosophila</italic>. FEBS Lett. 2006;580:4602&#x02013;6.<pub-id pub-id-type="pmid">16875690</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>TH</given-names></name><name><surname>Lu</surname><given-names>YN</given-names></name><name><surname>Chuang</surname><given-names>CL</given-names></name><name><surname>Wu</surname><given-names>CL</given-names></name><name><surname>Chiang</surname><given-names>AS</given-names></name><name><surname>Krantz</surname><given-names>DE</given-names></name><etal/></person-group><article-title>Loss of vesicular dopamine release precedes tauopathy in degenerative dopaminergic neurons in a <italic>Drosophila</italic> model expressing human tau</article-title><source>Acta Neuropathol</source><year>2013</year><volume>125</volume><fpage>711</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">23494099</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Wu TH, Lu YN, Chuang CL, Wu CL, Chiang AS, Krantz DE, et al. Loss of vesicular dopamine release precedes tauopathy in degenerative dopaminergic neurons in a <italic>Drosophila</italic> model expressing human tau. Acta Neuropathol. 2013;125:711&#x02013;25.<pub-id pub-id-type="pmid">23494099</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Luan</surname><given-names>H</given-names></name><name><surname>Peabody</surname><given-names>NC</given-names></name><name><surname>Vinson</surname><given-names>CR</given-names></name><name><surname>White</surname><given-names>BH</given-names></name></person-group><article-title>Refined spatial manipulation of neuronal function by combinatorial restriction of transgene expression</article-title><source>Neuron</source><year>2006</year><volume>52</volume><fpage>425</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">17088209</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Luan H, Peabody NC, Vinson CR, White BH. Refined spatial manipulation of neuronal function by combinatorial restriction of transgene expression. Neuron. 2006;52:425&#x02013;36.<pub-id pub-id-type="pmid">17088209</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Ehrhardt E, Whitehead SC, Namiki S, Minegishi R, Siwanowicz I, Feng K, et al. Single-cell type analysis of wing premotor circuits in the ventral nerve cord of <italic>Drosophila melanogaster</italic>. bioRxiv. 2023. 10.1101/2023.05.31.542897.</mixed-citation></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname><given-names>D</given-names></name><name><surname>Harris</surname><given-names>R</given-names></name><name><surname>Williams</surname><given-names>DW</given-names></name><name><surname>Truman</surname><given-names>JW</given-names></name></person-group><article-title>Postembryonic lineages of the <italic>Drosophila</italic> ventral nervous system: Neuroglian expression reveals the adult hemilineage associated fiber tracts in the adult thoracic neuromeres</article-title><source>J Comp Neurol</source><year>2016</year><volume>524</volume><fpage>2677</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">26878258</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Shepherd D, Harris R, Williams DW, Truman JW. Postembryonic lineages of the <italic>Drosophila</italic> ventral nervous system: Neuroglian expression reveals the adult hemilineage associated fiber tracts in the adult thoracic neuromeres. J Comp Neurol. 2016;524:2677&#x02013;95.<pub-id pub-id-type="pmid">26878258</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>RM</given-names></name><name><surname>Pfeiffer</surname><given-names>BD</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Truman</surname><given-names>JW</given-names></name></person-group><article-title>Neuron hemilineages provide the functional ground plan for the <italic>Drosophila</italic> ventral nervous system</article-title><source>Elife</source><year>2015</year><volume>4</volume><fpage>e04493</fpage><pub-id pub-id-type="pmid">26193122</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Harris RM, Pfeiffer BD, Rubin GM, Truman JW. Neuron hemilineages provide the functional ground plan for the <italic>Drosophila</italic> ventral nervous system. Elife. 2015;4:e04493.<pub-id pub-id-type="pmid">26193122</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Lacin</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>HM</given-names></name><name><surname>Long</surname><given-names>X</given-names></name><name><surname>Singer</surname><given-names>RH</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Truman</surname><given-names>JW</given-names></name></person-group><article-title>Neurotransmitter identity is acquired in a lineage-restricted manner in the</article-title><source>Elife</source><year>2019</year><volume>8</volume><fpage>e43701</fpage><pub-id pub-id-type="pmid">30912745</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Lacin H, Chen HM, Long X, Singer RH, Lee T, Truman JW. Neurotransmitter identity is acquired in a lineage-restricted manner in the. Elife. 2019;8:e43701.<pub-id pub-id-type="pmid">30912745</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>DW</given-names></name><name><surname>Tyrer</surname><given-names>M</given-names></name><name><surname>Shepherd</surname><given-names>D</given-names></name></person-group><article-title>Tau and tau reporters disrupt central projections of sensory neurons in <italic>Drosophila</italic></article-title><source>J Comp Neurol</source><year>2000</year><volume>428</volume><fpage>630</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">11077417</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Williams DW, Tyrer M, Shepherd D. Tau and tau reporters disrupt central projections of sensory neurons in <italic>Drosophila</italic>. J Comp Neurol. 2000;428:630&#x02013;40.<pub-id pub-id-type="pmid">11077417</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Wittmann</surname><given-names>CW</given-names></name><name><surname>Wszolek</surname><given-names>MF</given-names></name><name><surname>Shulman</surname><given-names>JM</given-names></name><name><surname>Salvaterra</surname><given-names>PM</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Hutton</surname><given-names>M</given-names></name><etal/></person-group><article-title>Tauopathy in <italic>Drosophila</italic>: neurodegeneration without neurofibrillary tangles</article-title><source>Science</source><year>2001</year><volume>293</volume><fpage>711</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">11408621</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, et al. Tauopathy in <italic>Drosophila</italic>: neurodegeneration without neurofibrillary tangles. Science. 2001;293:711&#x02013;4.<pub-id pub-id-type="pmid">11408621</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Bainbridge</surname><given-names>SP</given-names></name><name><surname>Bownes</surname><given-names>M</given-names></name></person-group><article-title>Staging the metamorphosis of <italic>Drosophila melanogaster</italic></article-title><source>J Embryol Exp Morphol</source><year>1981</year><volume>66</volume><fpage>57</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">6802923</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Bainbridge SP, Bownes M. Staging the metamorphosis of <italic>Drosophila melanogaster</italic>. J Embryol Exp Morphol. 1981;66:57&#x02013;80.<pub-id pub-id-type="pmid">6802923</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Pilling</surname><given-names>AD</given-names></name><name><surname>Horiuchi</surname><given-names>D</given-names></name><name><surname>Lively</surname><given-names>CM</given-names></name><name><surname>Saxton</surname><given-names>WM</given-names></name></person-group><article-title>Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in <italic>Drosophila</italic> motor axons</article-title><source>Mol Biol Cell</source><year>2006</year><volume>17</volume><fpage>2057</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">16467387</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Pilling AD, Horiuchi D, Lively CM, Saxton WM. Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in <italic>Drosophila</italic> motor axons. Mol Biol Cell. 2006;17:2057&#x02013;68.<pub-id pub-id-type="pmid">16467387</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Estes</surname><given-names>PS</given-names></name><name><surname>Ho</surname><given-names>GL</given-names></name><name><surname>Narayanan</surname><given-names>R</given-names></name><name><surname>Ramaswami</surname><given-names>M</given-names></name></person-group><article-title>Synaptic localization and restricted diffusion of a <italic>Drosophila</italic> neuronal synaptobrevin-green fluorescent protein chimera in vivo</article-title><source>J Neurogenet</source><year>2000</year><volume>13</volume><fpage>233</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">10858822</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Estes PS, Ho GL, Narayanan R, Ramaswami M. Synaptic localization and restricted diffusion of a <italic>Drosophila</italic> neuronal synaptobrevin-green fluorescent protein chimera in vivo. J Neurogenet. 2000;13:233&#x02013;55.<pub-id pub-id-type="pmid">10858822</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname><given-names>D</given-names></name><name><surname>Sahota</surname><given-names>V</given-names></name><name><surname>Court</surname><given-names>R</given-names></name><name><surname>Williams</surname><given-names>DW</given-names></name><name><surname>Truman</surname><given-names>JW</given-names></name></person-group><article-title>Developmental organization of central neurons in the adult <italic>Drosophila</italic> ventral nervous system</article-title><source>J Comp Neurol</source><year>2019</year><volume>527</volume><fpage>2573</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">30919956</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Shepherd D, Sahota V, Court R, Williams DW, Truman JW. Developmental organization of central neurons in the adult <italic>Drosophila</italic> ventral nervous system. J Comp Neurol. 2019;527:2573&#x02013;98.<pub-id pub-id-type="pmid">30919956</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>McCloy</surname><given-names>RA</given-names></name><name><surname>Rogers</surname><given-names>S</given-names></name><name><surname>Caldon</surname><given-names>CE</given-names></name><name><surname>Lorca</surname><given-names>T</given-names></name><name><surname>Castro</surname><given-names>A</given-names></name><name><surname>Burgess</surname><given-names>A</given-names></name></person-group><article-title>Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events</article-title><source>Cell Cycle</source><year>2014</year><volume>13</volume><fpage>1400</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">24626186</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">McCloy RA, Rogers S, Caldon CE, Lorca T, Castro A, Burgess A. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. Cell Cycle. 2014;13:1400&#x02013;12.<pub-id pub-id-type="pmid">24626186</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>A</given-names></name><name><surname>Vigneron</surname><given-names>S</given-names></name><name><surname>Brioudes</surname><given-names>E</given-names></name><name><surname>Labb&#x000e9;</surname><given-names>JC</given-names></name><name><surname>Lorca</surname><given-names>T</given-names></name><name><surname>Castro</surname><given-names>A</given-names></name></person-group><article-title>Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>12564</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20538976</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Burgess A, Vigneron S, Brioudes E, Labb&#x000e9; JC, Lorca T, Castro A. Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci USA. 2010;107:12564&#x02013;9.<pub-id pub-id-type="pmid">20538976</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Mudher</surname><given-names>A</given-names></name><name><surname>Shepherd</surname><given-names>D</given-names></name><name><surname>Newman</surname><given-names>TA</given-names></name><name><surname>Mildren</surname><given-names>P</given-names></name><name><surname>Jukes</surname><given-names>JP</given-names></name><name><surname>Squire</surname><given-names>A</given-names></name><etal/></person-group><article-title>GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in <italic>Drosophila</italic></article-title><source>Mol Psychiatry</source><year>2004</year><volume>9</volume><fpage>522</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">14993907</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Mudher A, Shepherd D, Newman TA, Mildren P, Jukes JP, Squire A, et al. GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in <italic>Drosophila</italic>. Mol Psychiatry. 2004;9:522&#x02013;30.<pub-id pub-id-type="pmid">14993907</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Chee</surname><given-names>FC</given-names></name><name><surname>Mudher</surname><given-names>A</given-names></name><name><surname>Cuttle</surname><given-names>MF</given-names></name><name><surname>Newman</surname><given-names>TA</given-names></name><name><surname>MacKay</surname><given-names>D</given-names></name><name><surname>Lovestone</surname><given-names>S</given-names></name><etal/></person-group><article-title>Over-expression of tau results in defective synaptic transmission in <italic>Drosophila</italic> neuromuscular junctions</article-title><source>Neurobiol Dis</source><year>2005</year><volume>20</volume><fpage>918</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">16023860</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Chee FC, Mudher A, Cuttle MF, Newman TA, MacKay D, Lovestone S, et al. Over-expression of tau results in defective synaptic transmission in <italic>Drosophila</italic> neuromuscular junctions. Neurobiol Dis. 2005;20:918&#x02013;28.<pub-id pub-id-type="pmid">16023860</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>CM</given-names></name><name><surname>Bossing</surname><given-names>T</given-names></name><name><surname>Page</surname><given-names>A</given-names></name><name><surname>Shepherd</surname><given-names>D</given-names></name><name><surname>Mudher</surname><given-names>A</given-names></name></person-group><article-title>Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo</article-title><source>Acta Neuropathol</source><year>2010</year><volume>120</volume><fpage>593</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">20617325</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Cowan CM, Bossing T, Page A, Shepherd D, Mudher A. Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol. 2010;120:593&#x02013;604.<pub-id pub-id-type="pmid">20617325</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>E</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name></person-group><article-title>A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads</article-title><source>Acta Neuropathol</source><year>1994</year><volume>87</volume><fpage>554</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">7522386</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 1994;87:554&#x02013;67.<pub-id pub-id-type="pmid">7522386</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>I</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name></person-group><article-title>PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in <italic>Drosophila</italic></article-title><source>Cell</source><year>2004</year><volume>116</volume><fpage>671</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">15006350</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Nishimura I, Yang Y, Lu B. PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in <italic>Drosophila</italic>. Cell. 2004;116:671&#x02013;82.<pub-id pub-id-type="pmid">15006350</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><name><surname>Vanmechelen</surname><given-names>E</given-names></name></person-group><article-title>Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205</article-title><source>Neurosci Lett</source><year>1995</year><volume>189</volume><fpage>167</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7624036</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett. 1995;189:167&#x02013;9.<pub-id pub-id-type="pmid">7624036</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Baumann</surname><given-names>K</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name><name><surname>Biernat</surname><given-names>J</given-names></name><name><surname>Piwnica-Worms</surname><given-names>H</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><article-title>Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5</article-title><source>FEBS Lett</source><year>1993</year><volume>336</volume><fpage>417</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">8282104</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 1993;336:417&#x02013;24.<pub-id pub-id-type="pmid">8282104</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Mandelkow</surname><given-names>EM</given-names></name><name><surname>Drewes</surname><given-names>G</given-names></name><name><surname>Biernat</surname><given-names>J</given-names></name><name><surname>Gustke</surname><given-names>N</given-names></name><name><surname>Van Lint</surname><given-names>J</given-names></name><name><surname>Vandenheede</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau</article-title><source>FEBS Lett</source><year>1992</year><volume>314</volume><fpage>315</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">1334849</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, et al. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 1992;314:315&#x02013;21.<pub-id pub-id-type="pmid">1334849</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Praschberger</surname><given-names>R</given-names></name><name><surname>Kuenen</surname><given-names>S</given-names></name><name><surname>Schoovaerts</surname><given-names>N</given-names></name><name><surname>Kaempf</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Janssens</surname><given-names>J</given-names></name><etal/></person-group><article-title>Neuronal identity defines &#x003b1;-synuclein and tau toxicity</article-title><source>Neuron</source><year>2023</year><volume>111</volume><fpage>1577</fpage><lpage>90.e11</lpage><pub-id pub-id-type="pmid">36948206</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Praschberger R, Kuenen S, Schoovaerts N, Kaempf N, Singh J, Janssens J, et al. Neuronal identity defines &#x003b1;-synuclein and tau toxicity. Neuron. 2023;111:1577&#x02013;90.e11.<pub-id pub-id-type="pmid">36948206</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>C</given-names></name><name><surname>Shy</surname><given-names>D</given-names></name><name><surname>Spindler</surname><given-names>SR</given-names></name><name><surname>Fung</surname><given-names>S</given-names></name><name><surname>Pereanu</surname><given-names>W</given-names></name><name><surname>Younossi-Hartenstein</surname><given-names>A</given-names></name><etal/></person-group><article-title>Patterns of growth, axonal extension and axonal arborization of neuronal lineages in the developing <italic>Drosophila</italic> brain</article-title><source>Dev Biol</source><year>2009</year><volume>335</volume><fpage>289</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">19538956</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Larsen C, Shy D, Spindler SR, Fung S, Pereanu W, Younossi-Hartenstein A, et al. Patterns of growth, axonal extension and axonal arborization of neuronal lineages in the developing <italic>Drosophila</italic> brain. Dev Biol. 2009;335:289&#x02013;304.<pub-id pub-id-type="pmid">19538956</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Roussarie</surname><given-names>JP</given-names></name><name><surname>Yao</surname><given-names>V</given-names></name><name><surname>Rodriguez-Rodriguez</surname><given-names>P</given-names></name><name><surname>Oughtred</surname><given-names>R</given-names></name><name><surname>Rust</surname><given-names>J</given-names></name><name><surname>Plautz</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Selective neuronal vulnerability in Alzheimer&#x02019;s disease: a network-based analysis</article-title><source>Neuron</source><year>2020</year><volume>107</volume><fpage>821</fpage><lpage>35.e12</lpage><pub-id pub-id-type="pmid">32603655</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Roussarie JP, Yao V, Rodriguez-Rodriguez P, Oughtred R, Rust J, Plautz Z, et al. Selective neuronal vulnerability in Alzheimer&#x02019;s disease: a network-based analysis. Neuron. 2020;107:821&#x02013;35.e12.<pub-id pub-id-type="pmid">32603655</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>MG</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name></person-group><article-title>Tau pathology and neurodegeneration</article-title><source>Lancet Neurol</source><year>2013</year><volume>12</volume><fpage>609</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">23684085</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013;12:609&#x02013;22.<pub-id pub-id-type="pmid">23684085</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>WS</given-names></name></person-group><article-title>Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein</article-title><source>Dis Model Mech</source><year>2014</year><volume>7</volume><fpage>21</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">24396151</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Jackson WS. Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein. Dis Model Mech. 2014;7:21&#x02013;9.<pub-id pub-id-type="pmid">24396151</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><name><surname>Crowther</surname><given-names>RA</given-names></name><name><surname>Six</surname><given-names>J</given-names></name><name><surname>L&#x000fc;bke</surname><given-names>U</given-names></name><name><surname>Vandermeeren</surname><given-names>M</given-names></name><etal/></person-group><article-title>The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development</article-title><source>Proc Natl Acad Sci USA</source><year>1993</year><volume>90</volume><fpage>5066</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">8506352</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Goedert M, Jakes R, Crowther RA, Six J, L&#x000fc;bke U, Vandermeeren M, et al. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA. 1993;90:5066&#x02013;70.<pub-id pub-id-type="pmid">8506352</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Alafuzoff</surname><given-names>I</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>Kretzschmar</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry</article-title><source>Acta Neuropathol</source><year>2006</year><volume>112</volume><fpage>389</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">16906426</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389&#x02013;404.<pub-id pub-id-type="pmid">16906426</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Hanger</surname><given-names>DP</given-names></name><name><surname>Brion</surname><given-names>JP</given-names></name><name><surname>Gallo</surname><given-names>JM</given-names></name><name><surname>Cairns</surname><given-names>NJ</given-names></name><name><surname>Luthert</surname><given-names>PJ</given-names></name><name><surname>Anderton</surname><given-names>BH</given-names></name></person-group><article-title>Tau in Alzheimer&#x02019;s disease and Down&#x02019;s syndrome is insoluble and abnormally phosphorylated</article-title><source>Biochem J</source><year>1991</year><volume>275</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">1826835</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Hanger DP, Brion JP, Gallo JM, Cairns NJ, Luthert PJ, Anderton BH. Tau in Alzheimer&#x02019;s disease and Down&#x02019;s syndrome is insoluble and abnormally phosphorylated. Biochem J. 1991;275:99&#x02013;104.<pub-id pub-id-type="pmid">1826835</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Drewes</surname><given-names>G</given-names></name><name><surname>Ebneth</surname><given-names>A</given-names></name><name><surname>Preuss</surname><given-names>U</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><article-title>MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption</article-title><source>Cell</source><year>1997</year><volume>89</volume><fpage>297</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">9108484</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell. 1997;89:297&#x02013;308.<pub-id pub-id-type="pmid">9108484</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Ebneth</surname><given-names>A</given-names></name><name><surname>Godemann</surname><given-names>R</given-names></name><name><surname>Stamer</surname><given-names>K</given-names></name><name><surname>Illenberger</surname><given-names>S</given-names></name><name><surname>Trinczek</surname><given-names>B</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><article-title>Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer&#x02019;s disease</article-title><source>J Cell Biol</source><year>1998</year><volume>143</volume><fpage>777</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">9813097</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer&#x02019;s disease. J Cell Biol. 1998;143:777&#x02013;94.<pub-id pub-id-type="pmid">9813097</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>McInnes</surname><given-names>J</given-names></name><name><surname>Wierda</surname><given-names>K</given-names></name><name><surname>Holt</surname><given-names>M</given-names></name><name><surname>Herrmann</surname><given-names>AG</given-names></name><name><surname>Jackson</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Tau association with synaptic vesicles causes presynaptic dysfunction</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>15295</fpage><pub-id pub-id-type="pmid">28492240</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Zhou L, McInnes J, Wierda K, Holt M, Herrmann AG, Jackson RJ, et al. Tau association with synaptic vesicles causes presynaptic dysfunction. Nat Commun. 2017;8:15295.<pub-id pub-id-type="pmid">28492240</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Stowers</surname><given-names>RS</given-names></name><name><surname>Megeath</surname><given-names>LJ</given-names></name><name><surname>G&#x000f3;rska-Andrzejak</surname><given-names>J</given-names></name><name><surname>Meinertzhagen</surname><given-names>IA</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><article-title>Axonal transport of mitochondria to synapses depends on milton, a novel <italic>Drosophila</italic> protein</article-title><source>Neuron</source><year>2002</year><volume>36</volume><fpage>1063</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">12495622</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Stowers RS, Megeath LJ, G&#x000f3;rska-Andrzejak J, Meinertzhagen IA, Schwarz TL. Axonal transport of mitochondria to synapses depends on milton, a novel <italic>Drosophila</italic> protein. Neuron. 2002;36:1063&#x02013;77.<pub-id pub-id-type="pmid">12495622</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>E</given-names></name><name><surname>Eser</surname><given-names>R</given-names></name><name><surname>Piergies</surname><given-names>A</given-names></name><name><surname>Sit</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Molecular characterization of selectively vulnerable neurons in Alzheimer&#x02019;s disease</article-title><source>Nat Neurosci</source><year>2021</year><volume>24</volume><fpage>276</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">33432193</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Leng K, Li E, Eser R, Piergies A, Sit R, Tan M, et al. Molecular characterization of selectively vulnerable neurons in Alzheimer&#x02019;s disease. Nat Neurosci. 2021;24:276&#x02013;87.<pub-id pub-id-type="pmid">33432193</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Davie</surname><given-names>K</given-names></name><name><surname>Janssens</surname><given-names>J</given-names></name><name><surname>Koldere</surname><given-names>D</given-names></name><name><surname>De Waegeneer</surname><given-names>M</given-names></name><name><surname>Pech</surname><given-names>U</given-names></name><name><surname>Kreft</surname><given-names>&#x00141;</given-names></name><etal/></person-group><article-title>A single-cell transcriptome atlas of the aging <italic>Drosophila</italic> brain</article-title><source>Cell</source><year>2018</year><volume>174</volume><fpage>982</fpage><lpage>98.e20</lpage><pub-id pub-id-type="pmid">29909982</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Davie K, Janssens J, Koldere D, De Waegeneer M, Pech U, Kreft &#x00141;, et al. A single-cell transcriptome atlas of the aging <italic>Drosophila</italic> brain. Cell. 2018;174:982&#x02013;98.e20.<pub-id pub-id-type="pmid">29909982</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Janssens</surname><given-names>J</given-names></name><name><surname>De Waegeneer</surname><given-names>M</given-names></name><name><surname>Kolluru</surname><given-names>SS</given-names></name><name><surname>Davie</surname><given-names>K</given-names></name><name><surname>Gardeux</surname><given-names>V</given-names></name><etal/></person-group><article-title>Fly cell atlas: a single-nucleus transcriptomic atlas of the adult fruit fly</article-title><source>Science</source><year>2022</year><volume>375</volume><fpage>eabk2432</fpage><pub-id pub-id-type="pmid">35239393</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Li H, Janssens J, De Waegeneer M, Kolluru SS, Davie K, Gardeux V, et al. Fly cell atlas: a single-nucleus transcriptomic atlas of the adult fruit fly. Science. 2022;375:eabk2432.<pub-id pub-id-type="pmid">35239393</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>AM</given-names></name><name><surname>Neville</surname><given-names>MC</given-names></name><name><surname>Birtles</surname><given-names>S</given-names></name><name><surname>Croset</surname><given-names>V</given-names></name><name><surname>Treiber</surname><given-names>CD</given-names></name><name><surname>Waddell</surname><given-names>S</given-names></name><etal/></person-group><article-title>A single-cell transcriptomic atlas of the adult</article-title><source>Elife</source><year>2020</year><volume>9</volume><fpage>e54074</fpage><pub-id pub-id-type="pmid">32314735</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Allen AM, Neville MC, Birtles S, Croset V, Treiber CD, Waddell S, et al. A single-cell transcriptomic atlas of the adult. Elife. 2020;9:e54074.<pub-id pub-id-type="pmid">32314735</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Possenti</surname><given-names>A</given-names></name><name><surname>Freer</surname><given-names>R</given-names></name><name><surname>Nakano</surname><given-names>Y</given-names></name><name><surname>Hernandez Villegas</surname><given-names>NC</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><etal/></person-group><article-title>A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology</article-title><source>Nat Neurosci</source><year>2019</year><volume>22</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">30559469</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Fu H, Possenti A, Freer R, Nakano Y, Hernandez Villegas NC, Tang M, et al. A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology. Nat Neurosci. 2019;22:47&#x02013;56.<pub-id pub-id-type="pmid">30559469</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>S</given-names></name><name><surname>Caroni</surname><given-names>P</given-names></name></person-group><article-title>Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration</article-title><source>Neuron</source><year>2011</year><volume>71</volume><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">21745636</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Saxena S, Caroni P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron. 2011;71:35&#x02013;48.<pub-id pub-id-type="pmid">21745636</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Ciryam</surname><given-names>P</given-names></name><name><surname>Kundra</surname><given-names>R</given-names></name><name><surname>Freer</surname><given-names>R</given-names></name><name><surname>Morimoto</surname><given-names>RI</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>Vendruscolo</surname><given-names>M</given-names></name></person-group><article-title>A transcriptional signature of Alzheimer&#x02019;s disease is associated with a metastable subproteome at risk for aggregation</article-title><source>Proc Natl Acad Sci USA</source><year>2016</year><volume>113</volume><fpage>4753</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">27071083</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Ciryam P, Kundra R, Freer R, Morimoto RI, Dobson CM, Vendruscolo M. A transcriptional signature of Alzheimer&#x02019;s disease is associated with a metastable subproteome at risk for aggregation. Proc Natl Acad Sci USA. 2016;113:4753&#x02013;8.<pub-id pub-id-type="pmid">27071083</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Freer</surname><given-names>R</given-names></name><name><surname>Sormanni</surname><given-names>P</given-names></name><name><surname>Vecchi</surname><given-names>G</given-names></name><name><surname>Ciryam</surname><given-names>P</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>Vendruscolo</surname><given-names>M</given-names></name></person-group><article-title>A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer&#x02019;s disease</article-title><source>Sci Adv</source><year>2016</year><volume>2</volume><fpage>e1600947</fpage><pub-id pub-id-type="pmid">27532054</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Freer R, Sormanni P, Vecchi G, Ciryam P, Dobson CM, Vendruscolo M. A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer&#x02019;s disease. Sci Adv. 2016;2:e1600947.<pub-id pub-id-type="pmid">27532054</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Duff</surname><given-names>KE</given-names></name></person-group><article-title>Selective vulnerability in neurodegenerative diseases</article-title><source>Nat Neurosci</source><year>2018</year><volume>21</volume><fpage>1350</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">30250262</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Fu H, Hardy J, Duff KE. Selective vulnerability in neurodegenerative diseases. Nat Neurosci. 2018;21:1350&#x02013;8.<pub-id pub-id-type="pmid">30250262</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Murdock</surname><given-names>MH</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name></person-group><article-title>Insights into Alzheimer&#x02019;s disease from single-cell genomic approaches</article-title><source>Nat Neurosci</source><year>2023</year><volume>26</volume><fpage>181</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">36593328</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Murdock MH, Tsai LH. Insights into Alzheimer&#x02019;s disease from single-cell genomic approaches. Nat Neurosci. 2023;26:181&#x02013;95.<pub-id pub-id-type="pmid">36593328</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>